leisure time -WSS

leisure time

author：Wikipedia 2025-08-12 09:08:39 - browse：77

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

WSS

An inside look at PIPEs, biotech's buzzy new financing tool

New menopause drug shows promise in relief for hot flashes

Pfizer highlights cancer drugs it thinks could reignite investor interest

A Q&A with Aletha Maybank, AMA’s chief health equity officer

RaDonda Vaught to speak at CommonSpirit event on patient safety

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Wikipedia

leisure time

knowledge

Walensky prepares to leave CDC — and Congress — behind

An inside look at PIPEs, biotech's buzzy new financing tool

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Continuity nursing helped my family in our darkest PICU moments

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Hepatitis C has a cure — but many Americans still lack access to it

FDA does about

In Memoriam: Notable people who died in 2023

Doulas covered by Medicaid under New York's new plan

hotspot

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

FogPharma raises $145 million in rare Series E round

Medical device lobby: We're tired of waiting on Medicare coverage

Change Healthcare cyberattack outage could last weeks

DeSantis can now import cheaper drugs. But will Biden get credit?

Congress gives doctors Medicare pay bump

focus

explore

knowledge

entertainment